What have we learned from worldwide experiences on the management and treatment of hospital effluent? - An overview and a discussion on perspectives

Science of the Total Environment

Volumn 514, Issue , 2015, Pages 467-491

  Verlicchi, P ^a   Al Aukidy, M ^a   Zambello, E ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Advanced oxidation processes; Environmental risk assessment; Hospital effluent; Pharmaceutical removal; Toxicity; Treatment costs

Indexed keywords

ACTIVATED CARBON; BIODEGRADATION; BIOLOGICAL WATER TREATMENT; BIOREACTORS; EFFLUENT TREATMENT; EFFLUENTS; FILTRATION; HOSPITALS; IMPURITIES; MEMBRANE TECHNOLOGY; MICROFILTRATION; OXIDATION; OXIDATION RESISTANCE; OZONE WATER TREATMENT; OZONIZATION; POLISHING; RISK ASSESSMENT; SURFACE WATERS; TOXICITY; WASTEWATER TREATMENT;

ADVANCED OXIDATION PROCESSES; BEST AVAILABLE TREATMENTS; ENVIRONMENTAL RISK ASSESSMENT; EXPERIMENTAL INVESTIGATIONS; HOSPITAL EFFLUENT; TREATMENT COSTS; ULTRA-FILTRATION MEMBRANES; WASTEWATER TREATMENT TECHNOLOGIES;

ACTIVATED CARBON TREATMENT;

ACTIVATED CARBON; CONTRAST MEDIUM; WASTE WATER; WATER POLLUTANT;

BIOREACTOR; DRUG; EFFLUENT; ENVIRONMENTAL RISK; OXIDATION; RISK ASSESSMENT; TOXICITY; ULTRAFILTRATION; WASTE MANAGEMENT; WASTE TREATMENT; WATER POLLUTION;

ANTIBIOTIC RESISTANCE; BIOREMEDIATION; CHLORINATION; DISINFECTION; ECONOMIC ASPECT; ECOTOXICOLOGY; EFFLUENT; FENTON REACTION; HEALTH HAZARD; HOSPITAL WASTE; HUMAN; INTERMETHOD COMPARISON; MEMBRANE REACTOR; NANOFILTRATION; NONHUMAN; OXIDATION; OZONATION; PHYSICAL CHEMISTRY; REVERSE OSMOSIS; REVIEW; RISK ASSESSMENT; ULTRAFILTRATION; ULTRAVIOLET IRRADIATION; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT; ANALYSIS; BIOREACTOR; CHEMISTRY; FILTRATION; HOSPITAL; PREVENTION AND CONTROL; PROCEDURES; SEWAGE; STATISTICS AND NUMERICAL DATA; WASTE WATER; WATER POLLUTANT; WATER POLLUTION;

BIODEGRADATION, ENVIRONMENTAL; BIOREACTORS; FILTRATION; HOSPITALS; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL; WATER POLLUTION;

EID: 84923010167     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2015.02.020     Document Type: Review

References (96)

1. Abd El-Gawad H.A., Aly A.M. Assessment of aquatic environmental for wastewater management quality in the hospitals: a case study. Aust. J. Basic Appl. Sci. 2011, 5:474-482.
2. Acero J.L., Von Gunten U. Characterization of oxidation processes: ozonation and the AOP O-3/H2O2. J. Am. Water Works Assoc. 2001, 93:90-100.
3. Al Aukidy M., Verlicchi P., Voulvoulis N. A framework for the assessment of the environmental risk posed by pharmaceuticals originating from hospital effluents. Sci. Total Environ. 2014, 493:54-64.
4. Al-Hashimia M., Abbas T.R., Jasema Y.I. Performance of sequencing anoxic/anaerobic membrane bioreactor (SAM) system in hospital wastewater treatment and reuse. Eur. Sci. J. 2013, 9:169-180.
5. Andersen H.R., Chhetri R.K., Hansen M.S., Christensson M., Sundmark K., Sund C., et al. Staged MBBR optimized for pharmaceutical biodegradation and ozonation of hospital wastewater. Poster presentation at the 8th World Water Congress, Lisbon 2014.
6. 2 processes. Sep. Purif. Methods 2014, 132:561-567.
7. Azar A.M., Jelogir A.G., Bidhendi G.N., Mehrdadi N., Zaredar N., Poshtegal M.K. Investigation of optimal method for hospital wastewater treatment. J. Food Agric. Environ. 2010, 8:1199-1202.
8. Beier S., Köster S., Veltmann K., Schröder HFr, Pinnekamp J. Treatment of hospital wastewater effluent by nanofiltration and reverse osmosis. Water Sci. Technol. 2010, 61:1691-1698.
9. Beier S., Cramer C., Köster S., Mauer C., Palmowski L., Schröder HFr, et al. Full scale membrane bioreactor treatment of hospital wastewater as forerunner for hot-spot wastewater treatment solutions in high density urban areas. Water Sci. Technol. 2011, 63:66-71.
10. Beier S., Cramer C., Mauer C., Köster S., Schröder HFr, Pinnekamp J. MBR technology: A promising approach for the (pre-)treatment of hospital wastewater. Water Sci. Technol. 2012, 65:1648-1653.
11. Berto J., Rochenbach G.C., Barreiros M.A.B., Corrêa A.X.R., Peluso-Silva S., Radetski C.M. Physico-chemical, microbiological and ecotoxicological evaluation of a septic tank/Fenton reaction combination for the treatment of hospital wastewaters. Ecotoxicol. Environ. Saf. 2009, 72:1076-1081.
12. Beyene H., Redaie G. Assessment of waste stabilization ponds for the treatment of hospital wastewater: the case of Hawassa University Referral Hospital. World Appl. Sci. J. 2011, 15:142-150.
13. Boillot C., Bazin C., Tissot-Guerraz F., Droguet J., Perraud M., Cetre J.C., et al. Daily physicochemical, microbiological and ecotoxicological fluctuations of a hospital effluent according to technical and care activities. Sci. Total Environ. 2008, 403:113-129.
14. 2 powder for the treatment of polluted water. Appl. Catal. B Environ. 1998, 17:25-36.
15. Chiang C.F., Tsai C.T., Lin S.T., Huo C.P., Lo K.W. Disinfection of hospital wastewater by continuous ozonation. J. Environ. Sci. Health A 2003, A38(12):2895-2908.
16. Chitnis V., Chitnis S., Vaidya K., Ravikant S., Patil S., Chitnis D.S. Bacterial population changes in hospital effluent treatment plant in central india. Water Res. 2004, 38:441-447.
17. Clara M., Strenn B., Gans O., Martinez E., Kreuzinger N., Kroiss H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 2005, 39:4797-4807.
18. 2. Appl. Catal. B Environ. 2000, 24:L1-L5.
19. Crites R.W., Tchobanoglous G. Small and Decentralized Wastewater Management Systems 1998, WCB/McGraw-Hill Editor, New York.
20. Cruz-Morato C., Lucas D., Llorca M., Rodriguez-Mozaz S., Gorga M., Petrovic M., et al. Hospital wastewater treatment by fungal bioreactor: removal efficiency for pharmaceuticals and endocrine disruptor compounds. Sci. Total Environ. 2014, 493:365-376.
21. Cunningham V.L. Special characteristics of pharmaceuticals related to environmental fate. Pharmaceutical in the Environment - Sources, Fate, Effects and Risks 2008, 23-34. Springer Berlin Heidelberg. III ed. K. Kummerer (Ed.).
22. De Almeida C.A.A., Brenner C.G.B., Minetto L., Mallmann C.A., Martins A.F. Determination of anti-anxiety and anti-epileptic drugs in hospital effluent and a preliminary risk assessment. Chemosphere 2013, 93:2349-2355.
23. Emmanuel E., Keck G., Blanchard J.M., Vermande P., Perrodin Y. Toxicological effects of disinfections using sodium hypochlorite on aquatic organisms and its contribution to AOX formation in hospital wastewater. Environ. Int. 2004, 30:891-900.
24. Emmanuel E., Perrodin Y., Keck G., Blanchard J., Vermande P. Ecotoxicological risk assessment of hospital wastewater: a proposed framework for raw effluents discharging into urban sewer network. J. Hazard. Mater. 2005, 117:1-11.
25. Escher B.I., Baumgartner R., Koller M., Treyer K., Lienert J., McArdell C.S. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res. 2011, 45:75-92.
26. Gabarron S., Gómez M., Monclús H., Rodríguez-Roda I., Comas J. Ragging phenomenon characterisation and impact in a full-scale MBR. Water Sci. Technol. 2013, 67:810-816.
27. Gautam A.K., Kumar S., Sabumon P.C. Preliminary study of physico-chemical treatment options for hospital wastewater. J. Environ. Manag. 2007, 83:298-306.
28. Grundfos biobooster Wastewater Treatment at Herlev Hospital, Denmark available at the web site:, (last access on January 12th, 2015). http://www.herlevhospital.dk/NR/rdonlyres/74234BCB-4E38-4B84-9742-80FFCDB416AF/0/10988_Biobooster_Herlev_LOW_opslag.pdf.
29. Hijnen W.A.M., Beerendonk E.F., Medema G.J. Inactivation credit of UV radiation for viruses, bacteria and protozoan (oo)cysts in water: a review. Water Res. 2006, 40:3-22.
30. Joss A., Zabczynski S., Göbel A., Hoffmann B., Löffler D., McArdell C.S., et al. Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res. 2006, 40:1686-1696.
31. Kajitvichyanukul P., Suntronvipart N. Evaluation of biodegradability and oxidation degree of hospital wastewater using photo-Fenton process as the pretreatment method. J. Hazard. Mater. 2006, B138:384-391.
32. Kimura K., Toshima S., Amy G., Watanabe Y. Rejection of neutral endocrine disrupting compounds (EDCs) and the pharmaceutical active compounds (PhACs) by RO membranes. J. Membr. Sci. 2004, 245:71-78.
33. Kist L.T., Albrech C., Machado Ê.L. Hospital laundry wastewater disinfection with catalytic photoozonation. Clean Soil Air Water 2008, 36:775-780.
34. Kohler C., Venditti S., Igos E., Klepiszewski K., Benetto E., Cornelissen A. Elimination of pharmaceutical residues in biologically pre-treated hospital wastewater using advanced UV irradiation technology: a comparative assessment. J. Hazard. Mater. 2012, 239-240:70-77.
35. Korzeniewska E., Korzeniewska A., Harnisz M. Antibiotic resistant Escherichia coli in hospital and municipal sewage and their emission to the environment. Ecotoxicol. Environ. Saf. 2013, 91:96-102.
36. Kosma C.I., Lambropoulou D.A., Albanis T.A. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece. J. Hazard. Mater. 2010, 179:804-817.
37. Kovalova L., Siegrist H., Singer H., Wittmer A., McArdell C.S. Hospital wastewater treatment by membrane bioreactor: performance and efficiency for organic micropollutant elimination. Environ. Sci. Technol. 2012, 46:1536-1545.
38. Kovalova L., Siegrist H., Von Gunten U., Eugster J., Hagenbuch M., Wittmer A., et al. Elimination of micropollutants during post-treatment of hospital wastewater with powdered activated carbon, ozone, and U. Environ. Sci. Technol. 2013, 47:7899-7908.
39. Kreuzinger N., Clara M., Strenn B., Kroiss H. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater. Water Sci. Technol. 2004, 50:149-156.
40. Kummerer K. Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospital in relation to other sources - a review. Chemosphere 2001, 45:957-969.
41. Kummerer K., Erbe T., Gartiser S., Brinker L. AOX-emissions from hospital into municipal wastewater. Chemosphere 1998, 36:2437-2445.
42. Lee Y., Von Gunten U. Oxidative transformation of micropollutants during municipal wastewater treatment: comparison of kinetic aspects of selective (chlorine, chlorine dioxide, ferrate VI, and ozone) and non-selective oxidants (hydroxyl radical). Water Res. 2010, 44:555-566.
43. Lenz K., Koellensperger G., Hann S., Weissenbacher N., Mahnik S.N., Fuerhacker M. Fate of cancerostatic platinum compounds in biological wastewater treatment of hospital effluents. Chemosphere 2007, 69:1765-1774.
44. Lenz K., Mahnik S.N., Weissenbacher N., Mader R.M., Krenn P., Hann S., et al. Monitoring, removal and risk assessment of cytostatic drugs in hospital wastewater. Water Sci. Technol. 2007, 56:141-149.
45. Lienert J., Koller M., Konrad J., McArdell C.S., Schuwirth N. Multiple-criteria decision analysis reveals high stakeholder preference to remove pharmaceuticals from hospital wastewater. Environ. Sci. Technol. 2011, 45:3848-3857.
46. Liu Q., Zhou Y., Chen L., Zheng X. Application of MBR for hospital wastewater treatment in China. Desalination 2010, 250:605-608.
47. Lopez N., Deblonde T., Hartemann Ph. Les effluents liquids hospitaliers. Hygiènes 2010, 18:405-410.
48. Machado Ê.L., Kist L.T., Schmidt R., Hoeltz J.M., Dalberto D., Alcayaga E.L.A. Secondary hospital wastewater detoxification and disinfection by advanced oxidation processes. Environ. Technol. 2007, 28:1135-1143.
49. Mahnik S.N., Lenz K., Weissenbacher N., Mader R.M., Fuerhacker M. Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. Chemosphere 2007, 66:30-37.
50. Mahvi A., Rajabizadeh A., Fatehizadeh A., Yousefi N., Hosseini H., Ahmadian M. Survey wastewater treatment condition and effluent quality of Kerman Province hospitals. World Appl. Sci. J. 2009, 7:1521-1525.
51. Martins A.F., Vasconcelos T.G., Henriques D.M., Frank C.S., König A., Kümmerer K. Concentration of ciprofloxacin in Brazilian hospital effluent and preliminary risk assessment: a case study. Clean Soil Air Water 2008, 36:264-269.
52. McArdell C.S., Kovalova L., Siegrist H. Input and elimination of pharmaceuticals and disinfectants from hospital wastewater. Final Report 2011, (July).
53. Mesdaghinia A.R., Naddafi K., Nabizadeh R., Saeedi R., Zamanzadeh M. Wastewater characteristics and appropriate Method for wastewater management in the hospitals. Iran J. Public Health 2009, 38:34-40.
54. Monteiro S.C., Boxall A.B.A. Occurrence and fate of human pharmaceuticals in the environment. Rev. Environ. Contam. Toxicol. 2010, 202:53-154.
55. Mousaab A., Claire C., Magali C., Christophe D. Upgrading the performances of ultrafiltration membrane system coupled with activated sludge reactor by addition of biofilm supports for the treatment of hospital effluents. Chem. Eng. J. 2015, 262:456-463.
56. Mullot J., Karolak S., Fontova A., Levi Y. Modeling of hospital wastewater pollution by pharmaceuticals: first results of mediflux study carried out in three French hospitals. Water Sci. Technol. 2010, 62:2912-2919.
57. Nardi G., Feretti D., Bracchi U., Dorè F., Francesconi A., Grottolo M., et al. Acque reflue ospedaliere. Valutazione di un trattamento di disinfezione con biossido di cloro. Inquinamento 1995, 7:77-83.
58. 2. Water Sci. Technol. 2013, 67:854-862.
59. Ort C., Lawrence M., Reungoat J., Eagleham G., Carter S., Keller J. Determination of the fraction of pharmaceutical residues in wastewater originating from a hospital. Water Res. 2010, 44:605-615.
60. Panouillères M., Boillot C., Perrodin Y. Study of the combined effects of a peracetic acid-based disinfectant and surfactants contained in hospital effluents on daphnia magna. Ecotoxicology 2007, 16:327-340.
61. Pauwels B., Verstraete W. The treatment of hospital wastewater: an appraisal. J. Water Health 2006, 4:405-416.
62. Pauwels B., Fru Ngwa F., Deconinck S., Verstraete W. Effluent quality of a conventional activated sludge and a membrane bioreactor system treating hospital wastewater. Environ. Technol. 2006, 27:395-402.
63. Perrodin Y., Bazin C., Bony S., Devaux A., Bertrand-Krajewski J.L., Cren-Olivé C., et al. A priori assessment of ecotoxicological risks linked to building a hospital. Chemosphere 2013, 90:1037-1046.
64. Pharmafilter report Evaluation report Pharmafilter Full scale demonstration in the Reinier de Graaf Gasthuis (Hospital) Delft 2013, (Available at the web site: http://nieuwesanitatie.stowa.nl/upload/publicaties/STOWA%202013%2016%20LR.pdf (last access on January 12th 2015)).
65. PILLS Report Pharmaceutical residues in the aquatic system: - a challenge for the future. Final Report of the European Cooperation Project PILLS 2012, (available at the address: www.pills-project.eu (last access on January 5th 2015), Gelsenkircken September 2012).
66. Prado T., Silva D.M., Guilayn W.C., Rose T.L., Gaspar A.M.C., Miagostovich M.P. Quantification and molecular characterization of enteric viruses detected in effluents from two hospital wastewater treatment plants. Water Res. 2011, 45:1287-1297.
67. Prayitno Kusuma Z., Yanuwiadi B., Laksmono R.W., Kamahara H., Daimon H. Hospital wastewater treatment using aerated fixed film biofilter - ozonation (Af2b/O3). Adv. Environ. Biol. 2014, 8:1251-1259.
68. Rezaee A., Ansari M., Khavanin A., Sabzali A., Aryan M.M. Hospital wastewater treatment using an integrated anaerobic aerobic fixed film bioreactor. Am. J. Exp. Sci. 2005, 1:259-263.
69. Rizzo L., Manaia C., Merlin C., Schwartz T., Dagot C., Ploy M.C., Michael I., Fatta-Kassinos D. Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: a review. Sci. Total Environ. 2013, 447:345-360.
70. Rogers H.R. Sources, behaviour and fate of organic contaminants during sewage treatment and in sewage sludges. Sci. Total Environ. 1996, 185:3-26.
71. Santos L.H.M.L.M., Gros M., Rodriguez-Mozaz S., Delerue-Matos C., Pena A., et al. Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals. Sci. Total Environ. 2013, 461-462:302-316.
72. Sarafraz Sh., Khani M.R., Yaghmaeian K. Quality and quantity survey of hospital wastewater in Hormozgan Province. Iran. J. Environ. Health Sci. Eng. 2007, 4:43-50.
73. Shrestha R.R., Haberl R., Laber J. Constructed wetland technology transfer to Nepal. Water Sci. Technol. 2001, 43:345-350.
74. Siegrest H., Joss A. Review on the fate of organic micropollutants in wastewater treatment and water reuse with membranes. Water Sci. Technol. 2012, 66:1369-1376.
75. Sim W.J., Kim H.Y., Choi S.D., Kwon J.H., Oh J.E. Evaluation of pharmaceuticals and personal care products with emphasis on anthelmintics in human sanitary waste, sewage, hospital wastewater, livestock wastewater and receiving water. J. Hazard. Mater. 2013, 248-249:219-227.
76. Sipibel Report Effluents hospitaliers et stations d'épuration urbaines: caractérisation, risques et traitabilité- Presentation and premiers resultants June, available at the web site, (last access on January 2nd, 2015). http://www.graie.org/Sipible/publications.html.
77. Straub J.O. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001. Toxicol. Lett. 2002, 131:137-143.
78. Suarez S., Lema J.M., Omil F. Pre-treatment of hospital wastewater by coagulation-flocculation and flotation. Bioresour. Technol. 2009, 100:2138-2146.
79. Suty H., De Traversay C., Cost M. Application of advanced oxidation processes: present and future. Water Sci. Technol. 2004, 49:227-233.
80. Tadkaew N., Hai F.I., McDonald J.A., Khan S.J., Nghiem L.D. Removal of trace organics by MBR treatment: the role of molecular properties. Water Res. 2011, 45:2439-2451.
81. Vasconcelos T.G., Kümmerer K., Henriques D.M., Martins A.F. Ciprofloxacin in hospital effluent: degradation by ozone and photoprocesses. J. Hazard. Mater. 2009, 169:1154-1158.
82. Venditti S., Köhler C., Arenz-Leufen M., O'Nagy O., Cornelissen A., Klepiszewski K. Membrane bioreactor process as pre-treatment for hospital effluents. Proceedings 8th IWA Leading-Edge Conference on Water and Wastewater Technologies, Amsterdam 2011.
83. Verlicchi P., Galletti A., Masotti L. Caratterizzazione e trattabilità di reflui ospedalieri: indagine sperimentale (con sistemi MBR) presso un ospedale dell'area ferrarese. Proceedings Sidisa Conference, Florence (Italy), June 2008 2008, (in Italian).
84. Verlicchi P., Galletti A., Masotti L. Management of hospital wastewaters: the case of the effluent of a large hospital situated in a small town. Water Sci. Technol. 2010, 61:2507-2519.
85. Verlicchi P., Galletti A., Al Aukidy M., Masotti L. New perspectives in wastewater disinfection. Water Disinfection 2011, 77-108. Nova Publisher.
86. Verlicchi P., Al Aukidy M., Galletti A., Petrovic M., Barceló D. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Sci. Total Environ. 2012, 430:109-118.
87. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after a secondary treatment-a review. Sci. Total Environ. 2012, 429:123-155.
88. Verlicchi P., Galletti A., Petrovic M., Barcelò D. Micro-pollutants in hospital effluent: their fate, risk and treatment options. Emerging Organic Contaminants and Human Health, the Handbook of Environmental Chemistry 2012, 139-172. Springer. D. Barcelò, A.G. Kostianoy (Eds.).
89. Verlicchi P., Zambello E., Al Aukidy M. Removal of pharmaceuticals by conventional wastewater treatment plants. Comprehensive Analytical Chemistry 2013, 231-286. Elsevier. D. Barcelò, M. Petrovic (Eds.).
90. von Gunten U. Ozonation of drinking water: part II. Disinfection and by-product formation. Water Res. 2003, 37:1469-1487.
91. Walhberg C., Biorlenius B., Paxeus N. Pharmaceuticals Residues in Stockholm Water Environment - Occurrence Mitigations and Treatment of Wastewater 2010, Stockolm Vatten, (in Swedish).
92. Wang X.W., Li J., Guo T., Zhen B., Kong Q., Yi B., et al. Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan hospital and the 309th Hospital of the Chinese People's Liberation Army. Water Sci. Technol. 2005, 52:213-221.
93. Wen X., Ding H., Huang X., Liu R. Treatment of hospital wastewater using a submerged membrane bioreactor. Process Biochem. 2004, 39:1427-1431.
94. Westerhoff P., Yoon Y., Snyder S., Wert E. Fate of endocrine-disruptor, pharmaceutical and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. Technol. 2005, 39:6649-6663.
95. 2+/ozonation. Water Res. 2014, 48:280-295.
96. Zwickenpflug B., Böhler M., Sterkele B., Joss A., Siegrist H., Traber J., Gujer W., Behl M., Dorusch F., Hollender J., Ternes T., Fink G. Einsatz von Pulveraktivkohle zur Elimination von Mikroverunreinigungen aus kommunalem Abwasser. Final report of the MicroPoll project EAWAG on behalf of the Swiss Federal Office for the Environment, Dübendorf, CH 2010, (http://www.eawag.ch/forschung/eng/schwerpunkte/ (last access on January 12th 2015)).